Athira Sethu
Kochi, 30 March 2026
Lupin’s subsidiary, Multicare Pharmaceuticals Philippines (MPPI), has repurchased 2,813,811 shares from the market. This affects the ownership of the company and increases the stake of one of the key owners, Nanomi.
Share Buyback Details
| Parameter | Details |
| Shares Repurchased | 2,813,811 |
| Nanomi’s Previous Stake | 51% |
| Nanomi’s Current Stake | 56.28% |
| Stake Increase | 5.28 points |
As a result of this repurchase, Nanomi’s stake in MPPI is now higher. The ownership stake increased by 5.28%, from 51% to 56.28%.
Why This Matters
Repurchasing shares is a tactic that helps make Lupin’s company more controlled by its key owners. With fewer shares in circulation, Nanomi and other key shareholders have higher control over MPPI. This helps them make key decisions and run the company as they wish.
Corporate Impact
This is significant for Lupin as it indicates that it is running its subsidiaries properly. The repurchase also indicates that Lupin is improving its corporate structure. The repurchase is also an indication that Lupin is confident in the growth prospects of MPPI in the near future.
Lupin Historical Stock Returns
| Period | Return |
| 1 Day | -0.72% |
| 5 Days | -0.26% |
| 1 Month | +0.63% |
| 6 Months | +20.66% |
| 1 Year | +14.75% |
| 5 Years | +130.29% |
Lupin’s stock has increased significantly over time, especially in the last five years.
(This information is for educational purposes only. Please consult your financial advisor before investing in stocks)
